Critical Care Diagnostics Market Regional Analysis:
North American Market Insights
The critical care diagnostics market in North America industry is predicted to hold largest revenue share of 45% by 2035. The yearly growth rate of U.S. healthcare spending is currently over 1% higher than the GDP, and the amount spent on healthcare in the United States will total around USD 6 trillion by 2028, or over 15% of GDP. Particularly, in 2022, US healthcare spending increased by more than 4%. As a result, hospitals hugely investing in advanced diagnostic technologies, leading to an increase in accessibility to advanced imaging systems, and point-of-care testing devices necessary in critical care settings.
APAC Market Insights
The Asia Pacific critical care diagnostics market is estimated to the second largest revenue share, during the forecast period, led by the rising medical tourism. India has become a significant medical tourism hub in recent years, owing to its low-cost treatments, presence of highly skilled and specialized medical professionals, and state-of-the-art medical facilities.
